Advances in clinical chemistry and laboratory medicine /
Saved in:
Meeting name: | IFCC WorldLab (2011 : Berlin, Germany) |
---|---|
Imprint: | Berlin ; Boston : Walter De Gruyter, ©2012. |
Description: | 1 online resource (xviii, 145 pages) : illustrations |
Language: | English |
Subject: | |
Format: | E-Resource Book |
URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/11169067 |
Table of Contents:
- Frontmatter
- Preface
- Table of Contents
- Authors Index
- 1 Plenary Articles
- 1.1 Proteomics strategies targeting biomarkers for cardiovascular disease
- 1.2 Influence of pre-examination aspects on result's validity
- are ISO 15189 requirements sufficient and clear?
- 1.3 Posttranslational modifications in tumor diagnosis
- 1.4 Chronic inflammatory disease: a result of complex gene-environment interaction
- 2 Symposium Articles
- 2.1 Component-array technology diagnostics: a step forward in the study of the sensitization profile of allergic patients
- 2.2 Pediatric metabolic syndrome: pathophysiology and molecular mechanisms
- 2.3 Urinary 8-hydroxydeoxyguanosine as a biomarker of microangiopathic complications in type 2 diabetic patients
- 2.4 Biological variation data: the need for appraisal of the evidence base
- 2.5 Recovery ELISA
- a newly-developed immunoassay for measurement of therapeutic antibodies and the target antigen during antibody therapy
- 2.6 Genotypic prediction of HIV-1 tropism from plasma and peripheral blood mononuclear cells in the clinical routine laboratory
- 2.7 Expression of a subset of microRNAs in clinically non-functioning pituitary adenomas correlates with tumor size
- 2.8 Serological markers of gastric pathology
- 2.9 BNP as a biomarker of cardiac impairment in neonates with congenital heart diseases
- 2.10 Are 25-hydroxyvitamin D assays fit for purpose?
- 2.11 Update on multiple sclerosis
- 2.12 Microalbuminuria and urinary retinol binding protein as markers of subtle renal injury in visceral leishmaniasis: sensitivity, specificity and predictive values of the immunoturbidimetric technique
- 2.13 Occult hepatitis B virus infection: diagnosis and significance
- 2.14 Unmet needs in chronic kidney disease testing
- 2.15 Towards a national chronic kidney disease testing program
- 2.16 Biochemistry and metabolism of vitamin D
- 2.17 Diagnostics of thalassemia
- 2.18 The specific roles of assessors during accreditation
- 2.19 Laboratory diagnosis of hereditary spherocytosis
- 2.20 Quantification of blood folate forms using stable-isotope dilution ultra performance liquid chromatography tandem mass spectrometry
- 2.21 Evaluation of the new Marburg cerebrospinal fluid model with human spondylopathies
- 2.22 E-learning experiences of national societies of clinical chemistry and laboratory medicine
- 2.23 The experience of Médecins Sans Frontières in laboratory medicine in resource-limited settings
- 2.24 Screening, identifying, and quantifying small molecules by hyphenated mass spectrometry in toxicology and drug monitoring
- an update
- 2.25 Analytical quality in the Latin America area
- 2.26 Standardization in molecular diagnostics: definitions and uses of nucleic acid reference materials
- 2.27 Profiling of antiphospolipid antibodies
- association with cerebrovascular events in APS
- 2.28 Plasma levels of soluble CD30 and CD40L in pediatric patients after liver transplantation
- 2.29 Diagnostic and prognostic value of presepsin (soluble CD14 subtype) in emergency patients with early sepsis using the new assay PATHFAST presepsin
- 2.30 Diagnostic workup of primary aldosteronism
- 2.31 What should the clinical laboratory and the toxicologist-pharmacologist offer the poisoned patient?
- 2.32 Novel aspects of the von Willebrand factor
- platelet glycoprotein IB interaction and signaling
- 2.33 Medical emergencies: what is the laboratory's role?